OVERVIEW

Amid the COVID-19 outbreak, the market size of the anatomic pathology track and trace solutions is calculated to reach USD 1.56 billion by 2026, growing at a CAGR of 9.4% during the forecast period. The rising volume of diagnostic tests conducted in anatomic pathology laboratories and the increasing number of legal cases involving cancer misdiagnosis are key drivers of market growth. In the following report, the impact of the COVID-19 outbreak on the industry will be fully assessed. The reports also compares the markets of Pre COVID-19 and Post COVID-19.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Anatomic Pathology Track and Trace Solutions Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Anatomic Pathology Track and Trace Solutions Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Anatomic Pathology Track and Trace Solutions Market ? Industry Market Entry

• • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Anatomic Pathology Track and Trace Solutions Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Anatomic Pathology Track and Trace Solutions Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Anatomic Pathology Track and Trace Solutions Market ? By Product (Market Size ? &million/billion)
  • 8.1 Software
  • 8.2 Hardware
  • 8.3 Consumables

• 9 Global Anatomic Pathology Track and Trace Solutions Market - By Technology
  • 9.1 Barcode
  • 9.2 RFID

• 10 Global Anatomic Pathology Track and Trace Solutions Market - By Application
  • 10.1 Slides Tracking
  • 10.2 Tissue Cassettes & Blocks Tracking
  • 10.3 Specimen Tracking

• 11 Global Anatomic Pathology Track and Trace Solutions Market - By End-User
  • 11.1 Hospital Laboratories
  • 11.2 Independent and Reference Laboratories
  • 11.3 Other

• 12 Global Anatomic Pathology Track and Trace Solutions Market ? By Geography (Market Size ? & million/billion)
  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global Anatomic Pathology Track and Trace Solutions Market ? Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global Anatomic Pathology Track and Trace Solutions Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Thermo Fisher Scientific Inc.
  • 14.3 Leica Biosystems Nussloch GmbH (Subsidiary of Danaher Corporation)
  • 14.4 General Data Healthcare Inc.
  • 14.5 Ventana Medical Systems, Inc.
  • 14.6 Zebra Technologies Corporation
  • 14.7 Primera Technology, Inc.
  • 14.8 Agilent Technologies, Inc.
  • 14.9 Sunquest Information Systems, Inc.
  • 14.10 Cerebrum Corp
  • 14.11 AP Easy Software Solutions
  • 14.12 Company 11 & more

• 15 Global Anatomic Pathology Track and Trace Solutions Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations